Cytokines regulate neuronal gene expression: Differential effects of Th1, Th2 and monocyte/macrophage cytokines

Journal of Neuroimmunology

Volumn 238, Issue 1-2, 2011, Pages 19-33

  Lisak, Robert P ^a,b   Nedelkoska, Liljana ^a   Studzinski, Diane ^c   Bealmear, Beverly ^a   Xu, Wenbo ^b   Benjamins, Joyce A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c BEAUMONT HOSPITAL   (United States)

Author keywords

Cytokines; Glia; Inflammation; Multiple sclerosis; Neurodegeneration

Indexed keywords

ADIPOCYTOKINE; ARGINASE; CD69 ANTIGEN; CD74 ANTIGEN; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RANTES; SCLEROPROTEIN; STROMELYSIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; ASTROCYTE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE NUMBER; GLIA CELL; IMMUNOPATHOGENESIS; MACROPHAGE; MONOCYTE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYTOKINES; DRUG COMBINATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MACROPHAGES; MONOCYTES; NERVE TISSUE PROTEINS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS; UBIQUITIN;

EID: 80052858860     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.010     Document Type: Article

References (139)

1. Aarum J., Sandberg K., Haeberlein S.L., Persson M.A. Migration and differentiation of neural precursor cells can be directed by microglia. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15983-15988.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
3. Arevalo J.C., Chao M.V. Axonal growth: where neurotrophins meet Wnts. Curr. Opin. Cell Biol. 2005, 17:112-115.
4. Bartels A.L., Leenders K.L. Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov. Disord. 2007, 22:1852-1856.
5. Bates E.E., Ravel O., Dieu M.C., Ho S., Guret C., Bridon J.M., Ait-Yahia S., Briere F., Caux C., Banchereau J., Lebecque S. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur. J. Immunol. 1997, 27:2471-2477.
6. Bjartmar C., Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 2001, 14:271-278.
7. Bjartmar C., Trapp B.D. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox. Res. 2003, 5:157-164.
8. Bjartmar C., Wujek J.R., Trapp B.D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 2003, 206:165-171.
9. Bo L., Vedeler C.A., Nyland H., Trapp B.D., Mork S.J. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult. Scler. 2003, 9:323-331.
10. Bo L., Vedeler C.A., Nyland H.I., Trapp B.D., Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 2003, 62:723-732.
11. Bozkulak E.C., Weinmaster G. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 2009, 29:5679-5695.
12. Brodie C. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes. FEBS Lett. 1996, 394:117-120.
13. Brodie C., Goldreich N., Haiman T., Kazimirsky G. Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J. Neuroimmunol. 1998, 81:20-30.
14. Butovsky O., Bukshpan S., Kunis G., Jung S., Schwartz M. Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol. Cell. Neurosci. 2007, 35:490-500.
15. Cai D., Deng K., Mellado W., Lee J., Ratan R.R., Filbin M.T. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron 2002, 35:711-719.
16. Cantarella G., Di Benedetto G., Pezzino S., Risuglia N., Bernardini R. TRAIL-related neurotoxicity implies interaction with the Wnt pathway in human neuronal cells in vitro. J. Neurochem. 2008, 105:1915-1923.
17. Chapouton P., Skupien P., Hesl B., Coolen M., Moore J.C., Madelaine R., Kremmer E., Faus-Kessler T., Blader P., Lawson N.D., Bally-Cuif L. Notch activity levels control the balance between quiescence and recruitment of adult neural stem cells. J. Neurosci. 2010, 30:7961-7974.
18. Chen M., Valenzuela R.M., Dhib-Jalbut S. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor. J. Neurol. Sci. 2003, 215:37-44.
19. Cifelli A., Arridge M., Jezzard P., Esiri M.M., Palace J., Matthews P.M. Thalamic neurodegeneration in multiple sclerosis. Ann. Neurol. 2002, 52:650-653.
20. De Ferrari G.V., Inestrosa N.C. Wnt signaling function in Alzheimer's disease. Brain Res. Brain Res. Rev. 2000, 33:1-12.
21. DeLuca G.C., Ebers G.C., Esiri M.M. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004, 127:1009-1018.
22. Dijkstra C.D., Van Vliet E., Dopp E.A., van der Lelij A.A., Kraal G. Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 1985, 55:23-30.
23. Doucette R. Glial influences on axonal growth in the primary olfactory system. Glia 1990, 3:433-449.
24. Du Y., Dreyfus C.F. Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 2002, 68:647-654.
25. Dutta R., Chang A., Doud M., Kidd G., Ribuado M., Young E., Foxm R.J., Staugaitis S., Trapp B. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann. Neurol. 2011, 69:445-454.
26. Dutta R., McDonough J., Chang A., Swamy L., Siu A., Kidd G.J., Rudick R., Mirnics K., Trapp B.D. Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients. Brain 2007, 130:2566-2576.
27. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., Gudz T., Macklin W.B., Lewis D.A., Fox R.J., Rudick R., Mirnics K., Trapp B.D. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 2006, 59:478-489.
28. Dutta R., Trapp B.D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007, 68:S22-S31. discussion S43-54.
29. Dutta R., Trapp B.D. Gene expression profiling in multiple sclerosis brain. Neurobiol. Dis. 2010, Dec 13 (Epub ahead of print).
30. Dutta R., Trapp B.D. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog. Neurobiol. 2010, 93:1-12.
31. Ebstein F., Lange N., Urban S., Seifert U., Kruger E., Kloetzel P.M. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 2009, 41:1205-1215.
32. Eide L., McMurray C.T. Culture of adult mouse neurons. Biotechniques 2005, 38:99-104.
33. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
34. Elstner M., Morris C.M., Heim K., Lichtner P., Bender A., Mehta D., Schulte C., Sharma M., Hudson G., Goldwurm S., Giovanetti A., Zeviani M., Burn D.J., McKeith I.G., Perry R.H., Jaros E., Kruger R., Wichmann H.E., Schreiber S., Campbell H., Wilson J.F., Wright A.F., Dunlop M., Pistis G., Toniolo D., Chinnery P.F., Gasser T., Klopstock T., Meitinger T., Prokisch H., Turnbull D.M. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann. Neurol. 2009, 66:792-798.
35. Estevez A.G., Sahawneh M.A., Lange P.S., Bae N., Egea M., Ratan R.R. Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons. J. Neurosci. 2006, 26:8512-8516.
36. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120:393-399.
37. Foidart J.M., Schaaps J.P., Chantraine F., Munaut C., Lorquet S. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J. Reprod. Immunol. 2009, 82:106-111.
38. Ganter P., Prince C., Esiri M.M. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol. Appl. Neurobiol. 1999, 25:459-467.
39. Giuliani F., Goodyer C.G., Antel J.P., Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 2003, 171:368-379.
40. Gong P., Canaan A., Wang B., Leventhal J., Snyder A., Nair V., Cohen C.D., Kretzler M., D'Agati V., Weissman S., Ross M.J. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J. Am. Soc. Nephrol. 2010, 21:316-326.
41. Graumann U., Reynolds R., Steck A.J., Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 2003, 13:554-573.
42. Greene J.G. Current status and future directions of gene expression profiling in Parkinson's disease. Neurobiol. Dis. 2010, Nov 5 (Epub ahead of print).
43. Greene J.G., Dingledine R., Greenamyre J.T. Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents. Neurobiol. Dis. 2010, 38:476-481.
44. Gruen J.R., Weissman S.M. Evolving views of the major histocompatibility complex. Blood 1997, 90:4252-4265.
45. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
46. Hannila S.S., Filbin M.T. The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp. Neurol. 2008, 209:321-332.
47. He P., Zhong Z., Lindholm K., Berning L., Lee W., Lemere C., Staufenbiel M., Li R., Shen Y. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 2007, 178:829-841.
48. Hensley K., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., Williamson K.S. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2006, 8:2075-2087.
49. Herrmann J., Lerman L.O., Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 2007, 100:1276-1291.
50. Hesse M., Modolell M., La Flamme A.C., Schito M., Fuentes J.M., Cheever A.W., Pearce E.J., Wynn T.A. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 2001, 167:6533-6544.
51. Hipp M.S., Kalveram B., Raasi S., Groettrup M., Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 2005, 25:3483-3491.
52. Hiremath M.M., Chen V.S., Suzuki K., Ting J.P., Matsushima G.K. MHC class II exacerbates demyelination in vivo independently of T cells. J. Neuroimmunol. 2008, 203:23-32.
53. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol. Sci. 2006, 27(Suppl 1):S1-S7.
54. Horesh Y., Katsel P., Haroutunian V., Domany E. Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus. Eur. J. Neurol. 2010, 18:410-424.
55. Inestrosa N.C., Toledo E.M. The role of Wnt signaling in neuronal dysfunction in Alzheimer's disease. Mol. Neurodegener. 2008, 3:9.
56. Jeitner T.M., Muma N.A., Battaile K.P., Cooper A.J. Transglutaminase activation in neurodegenerative diseases. Future Neurol. 2009, 4:449-467.
57. Jepsen K.J., Hu B., Tommasini S.M., Courtland H.W., Price C., Terranova C.J., Nadeau J.H. Genetic randomization reveals functional relationships among morphologic and tissue-quality traits that contribute to bone strength and fragility. Mamm. Genome 2007, 18:492-507.
58. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57:236-251.
59. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 2002, 8:1115-1121.
60. Jones L., Holmans P., Hamshere M., Harold D., Moskvina V., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010, 5(11):e13950. 1-10.
61. Jurynczyk M., Jurewicz A., Raine C.S., Selmaj K. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:2634-2640.
62. Kalveram B., Schmidtke G., Groettrup M. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J. Cell Sci. 2008, 121:4079-4088.
63. Kapoor R., Davies M., Blaker P.A., Hall S.M., Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 2003, 53:174-180.
64. Kong W., Mou X., Liu Q., Chen Z., Vanderburg C.R., Rogers J.T., Huang X. Independent component analysis of Alzheimer's DNA microarray gene expression data. Mol. Neurodegener. 2009, 4:5.
65. Kutzelnigg A., Lassmann H. Cortical lesions and brain atrophy in MS. J. Neurol. Sci. 2005, 233:55-59.
66. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
67. Lassmann H. Multiple sclerosis: is there neurodegeneration independent from inflammation?. J. Neurol. Sci. 2007, 259:3-6.
68. Lassmann H. Mechanisms of inflammation induced tissue injury in multiple sclerosis. J. Neurol. Sci. 2008, 274:45-47.
69. Lassmann H. What drives disease in multiple sclerosis: inflammation or neurodegeneration. Clin. Exp. Neuroimmunol. 2010, 1:2-11.
70. Li S., Jiang Q., Stys P.K. Important role of reverse Na(+)-Ca(2+) exchange in spinal cord white matter injury at physiological temperature. J. Neurophysiol. 2000, 84:1116-1119.
71. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol. Genomics 2008, 33:240-256.
72. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's disease neuropathology. Neurobiol. Aging 2010, 31:549-566.
73. Lie D.C., Colamarino S.A., Song H.J., Desire L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
74. Lisak R., Benjamins J., Bealmear B., Yao B., Land S., Skundric D.S. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for mmune-related molecules by central nervous system mixed glial cell cultures. Mult. Scler. 2006, 12:149-168.
75. Lisak R., Studzinski D., Bealmear B., Nedelkoska L., Benjamins J. Kinetics of gene expression in central nervous system glial cells induced by Th1, Th2 and monocyte/macrophage cytokines. Mult. Scler. 2005, 11(Suppl 2):S136-S137.
76. Lisak R.P. Neurodegeneration in multiple sclerosis: defining the problem. Neurology 2007, 68:S5-S12. discussion S43-54.
77. Lisak R.P., Benjamins J.A., Bealmear B., Nedelkoska L., Studzinski D., Retland E., Yao B., Land S. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J. Neuroinflammation 2009, 6:4.
78. Lisak R.P., Benjamins J.A., Bealmear B., Nedelkoska L., Yao B., Land S., Studzinski D. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins. J. Neuroinflammation 2007, 4:30.
79. Liu Y.C., Pan J., Zhang C., Fan W., Collinge M., Bender J.R., Weissman S.M. A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4313-4318.
80. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
81. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
82. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination [see comments]. Ann. Neurol. 2000, 47:707-717.
83. Mabb A.M., Ehlers M.D. Ubiquitination in postsynaptic function and plasticity. Annu. Rev. Cell Dev. Biol. 2010, 26:179-210.
84. Medana I.M., Gallimore A., Oxenius A., Martinic M.M., Wekerle H., Neumann H. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur. J. Immunol. 2000, 30:3623-3633.
85. Minagar A., Shapshak P., Duran E.M., Kablinger A.S., Alexander J.S., Kelley R.E., Seth R., Kazic T. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review. J. Neurol. Sci. 2004, 224:3-17.
86. Modolell M., Corraliza I.M., Link F., Soler G., Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 1995, 25:1101-1104.
87. Moon R.T., Kohn A.D., De Ferrari G.V., Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 2004, 5:691-701.
88. Mori M., Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. 2000, 275:715-719.
89. Mullen R.J., Buck C.R., Smith A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992, 116:201-211.
90. Muzio L., Martino G., Furlan R. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J. Neuroimmunol. 2007, 191:39-44.
91. Mycko M.P., Papoian R., Boschert U., Raine C.S., Selmaj K.W. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 2003, 126:1048-1057.
92. Nagler K., Mauch D.H., Pfrieger F.W. Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J. Physiol. 2001, 533:665-679.
93. Nave K.A., Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 2008, 31:535-561.
94. Nelson B.R., Hartman B.H., Georgi S.A., Lan M.S., Reh T.A. Transient inactivation of Notch signaling synchronizes differentiation of neural progenitor cells. Dev. Biol. 2007, 304:479-498.
95. Nixon R.A. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 2007, 120:4081-4091.
96. Omari K.M., John G., Lango R., Raine C.S. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 2006, 53:24-31.
97. Packard M., Mathew D., Budnik V. Wnts and TGF beta in synaptogenesis: old friends signalling at new places. Nat. Rev. Neurosci. 2003, 4:113-120.
98. Peterson J.W., Bo L., Mork S., Chang A., Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 2001, 50:389-400.
99. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 2001, 276:35334-35343.
100. Raff M.C., Mirsky R., Fields K.L., Lisak R.P., Dorfman S.H., Silberberg D.H., Gregson N.A., Leibowitz S., Kennedy M.C. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 1978, 274:813-816.
101. Ranscht B., Clapshaw P.A., Price J., Noble M., Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:2709-2713.
102. Ray M., Zhang W. Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks. BMC Syst. Biol. 2010, 4:136.
103. Rose J.J., Bealmear B., Nedelkoska L., Studzinski D., Lisak R.P., Benjamins J.A. Cytokines decrease expression of interleukin-6 signal transducer and leptin receptor in central nervous system glia. J. Neurosci. Res. 2009, 87:3098-3106.
104. Scherzer C.R. Chipping away at diagnostics for neurodegenerative diseases. Neurobiol. Dis. 2009, 35:148-156.
105. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64:40-45.
106. Shin J., Poling J., Park H.C., Appel B. Notch signaling regulates neural precursor allocation and binary neuronal fate decisions in zebrafish. Development 2007, 134:1911-1920.
107. Shruster A., Eldar-Finkelman H., Melamed E., Offen D. Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid beta-peptide. J. Neurochem. 2011, 116:522-529.
108. Simard A.R., Rivest S. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol. Psychiatry 2006, 11:327-335.
109. Simunovic F., Yi M., Wang Y., Macey L., Brown L.T., Krichevsky A.M., Andersen S.L., Stephens R.M., Benes F.M., Sonntag K.C. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 2009, 132:1795-1809.
110. Smith K.J., Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002, 1:232-241.
111. Stamper C., Siegel A., Liang W.S., Pearson J.V., Stephan D.A., Shill H., Connor D., Caviness J.N., Sabbagh M., Beach T.G., Adler C.H., Dunckley T. Neuronal gene expression correlates of Parkinson's disease with dementia. Mov. Disord. 2008, 23:1588-1595.
112. Sternberger L.A., Harwell L.W., Sternberger N.H. Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1326-1330.
113. Stys P.K. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 2005, 233:3-13.
114. Stys P.K., Waxman S.G., Ransom B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J. Neurosci. 1992, 12:430-439.
115. Suzumura A., Silberberg D.H., Lisak R.P. The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J. Neuroimmunol. 1986, 11:179-190.
116. Tajouri L., Mellick A.S., Ashton K.J., Tannenberg A.E., Nagra R.M., Tourtellotte W.W., Griffiths L.R. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res. Mol. Brain Res. 2003, 119:170-183.
117. Takano K., Shiraiwa K., Moriyama M., Nakamura Y. Transglutaminase 2 expression induced by lipopolysaccharide stimulation together with NO synthase induction in cultured astrocytes. Neurochem. Int. 2010, 57:812-818.
118. Tan M.G., Chua W.T., Esiri M.M., Smith A.D., Vinters H.V., Lai M.K. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J. Neurosci. Res. 2010, 88:1157-1169.
119. Tang K., Yang J., Gao X., Wang C., Liu L., Kitani H., Atsumi T., Jing N. Wnt-1 promotes neuronal differentiation and inhibits gliogenesis in P19 cells. Biochem. Biophys. Res. Commun. 2002, 293:167-173.
120. Taylor M.K., Yeager K., Morrison S.J. Physiological Notch signaling promotes gliogenesis in the developing peripheral and central nervous systems. Development 2007, 134:2435-2447.
121. Toledo E.M., Colombres M., Inestrosa N.C. Wnt Signaling in Neuroprotection and Stem Cell Differentiation 2008, Prog Neurobiol.
122. Town T., Laouar Y., Pittenger C., Mori T., Szekely C.A., Tan J., Duman R.S., Flavell R.A. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 2008, 14:681-687.
123. Townsend K.P., Obregon D., Quadros A., Patel N., Volmar C., Paris D., Mullan M. Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann. N. Y. Acad. Sci. 2002, 977:65-76.
124. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
125. Tydlacka S., Wang C.E., Wang X., Li S., Li X.J. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. J. Neurosci. 2008, 28:13285-13295.
126. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291:657-661.
127. van Strien M.E., Drukarch B., Bol J.G., van der Valk P., van Horssen J., Gerritsen W.H., Breve J.J., van Dam A.M. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?. Brain Pathol. 2011, 21:44-54.
128. Viehover A., Miller R.H., Park S.K., Fischbach G., Vartanian T. Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 2001, 23:377-386.
129. Villoslada P., Moreno B., Melero I., Pablos J.L., Martino G., Uccelli A., Montalban X., Avila J., Rivest S., Acarin L., Appel S., Khoury S.J., McGeer P., Ferrer I., Delgado M., Obeso J., Schwartz M. Immunotherapy for neurological diseases. Clin. Immunol. 2008, 128:294-305.
130. Waxman S.G. Demyelinating diseases-new pathological insights, new therapeutic targets. N. Engl. J. Med. 1998, 338:323-325.
131. Whitney L.W., Becker K.G., Tresser N.J., Caballero-Ramos C.I., Munson P.J., Prabhu V.V., Trent J.M., McFarland H.F., Biddison W.E. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 1999, 46:425-428.
132. Wolf S.A., Fisher J., Bechmann I., Steiner B., Kwidzinski E., Nitsch R. Neuroprotection by T-cells depends on their subtype and activation state. J. Neuroimmunol. 2002, 133:72-80.
133. Woodroofe M.N., Cuzner M.L. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 1993, 5:583-588.
134. Wujek J.R., Bjartmar C., Richer E., Ransohoff R.M., Yu M., Tuohy V.K., Trapp B.D. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J. Neuropathol. Exp. Neurol. 2002, 61:23-32.
135. Yao B., Rakhade S.N., Li Q., Ahmed S., Krauss R., Dragichi S., Loeb J. Accuracy of microarray methods to detect small gene expression changes induced by neuregulin in breast eptithelial cells. BMC Bioinformatics 2004, 5(1-6):99.
136. Yeo S.Y., Chitnis A.B. Jagged-mediated Notch signaling maintains proliferating neural progenitors and regulates cell diversity in the ventral spinal cord. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:5913-5918.
137. Yokota T., Mishra M., Akatsu H., Tani Y., Miyauchi T., Yamamoto T., Kosaka K., Nagai Y., Sawada T., Heese K. Brain site-specific gene expression analysis in Alzheimer's disease patients. Eur. J. Clin. Invest. 2006, 36:820-830.
138. Zeis T., Kinter J., Herrero-Herranz E., Weissert R., Schaeren-Wiemers N. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes. J. Neuroimmunol. 2008, 205:10-19.
139. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002, 125:2381-2391.